$6.48
0.00%
Nasdaq, Fri, Nov 15 2024
ISIN
US35655L1070
Symbol
FRLN
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Health
Industry
Biotechnology

Freeline Therapeutics Holdings plc - ADR Stock News

https://www.prnewswire.com/news-releases/freeline-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-freeline-therapeutics-holdings-plc---frln-302046013.html
https://www.prnewswire.com/news-releases/freeline-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-freeline-therapeutics-holdings-plc---frln-302046013.html

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today